Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05349903 · ClinicalTrials.gov registry record · NA
Impact of Slowly Digestible Carbohydrates on the Gut-brain Axis
A NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05349903: Completed NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by Purdue University.
NCT05349903 is a NA study of Obesity and Diabetes Mellitus, Type 2 that has completed, run by Purdue University. The registered enrollment target is 20 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05349903, a NA study of Obesity and Diabetes Mellitus, Type 2, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Our laboratory is investigating the physiological outcomes and health benefits of the consumption of high-quality carbohydrates. One important aspect of the high-quality carbohydrate characteristics is a slow and sustained digestion and glucose release to the blood. In the proposed study, the investigators will evaluate the consumption of different types of slowly digestible carbohydrates (SDCs) and their beneficial effects including moderation of the glycemic response profile (postprandial glycemic response, PPGR) and stimulation of the gut-brain axis, which controls appetite and food intake. This stimulation will be evaluated in terms of second-meal food intake and the circulatory level of appetite-suppressing gut hormones (such as glucagon-like peptide-1).
Primary Outcome
Blood plasma glucose will be measured, (AUC)
Conditions Studied
Interventions
- OTHER Inulin
- OTHER Rice flour
- OTHER Alternanoligosaccharide 15
- OTHER Waxy potato starch
- OTHER Waxy potato starch + epigallocatechin gallate (EGCG)
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2022-02-24 |
| Phase | NA |
What the finished NCT05349903 record still lists
NCT05349903 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Inulin is the first listed.
NCT05349903 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT05349903 about?
NCT05349903 is a clinical study titled "Impact of Slowly Digestible Carbohydrates on the Gut-brain Axis". Our laboratory is investigating the physiological outcomes and health benefits of the consumption of high-quality carbohydrates. One important aspect of the high-quality carbohydrate characteristics is a slow and sustained digestion and glucose release to the blood. In the proposed study, the invest...
What is the current status of trial NCT05349903?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-11-10. Estimated completion is 2022-02-24.
What conditions does trial NCT05349903 study?
This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2, Appetitive Behavior.
What interventions are being tested in trial NCT05349903?
The interventions under investigation include: Inulin (OTHER), Rice flour (OTHER), Alternanoligosaccharide 15 (OTHER), Waxy potato starch (OTHER), Waxy potato starch + epigallocatechin gallate (EGCG) (OTHER).
Who is sponsoring clinical trial NCT05349903?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05349903 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05349903's enrollment target sits among peer trials
20 946th of 1053 higher than 80 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI